Suppression of arthritis by the inhibitors of dipeptidyl peptidase IV
- 31 January 1997
- journal article
- Published by Elsevier BV in International Journal of Immunopharmacology
- Vol. 19 (1), 15-24
- https://doi.org/10.1016/s0192-0561(97)00004-0
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Unchanged Signaling Capacity of Mutant CD26/Dipeptidylpeptidase IV Molecules Devoid of Enzymatic ActivityCellular Immunology, 1995
- Solution Structures of Active and Inactive Forms of the DP IV (CD26) Inhibitor Pro-boroPro Determined by NMR SpectroscopyBiochemistry, 1994
- Dipeptidyl peptidase IV (DP IV) activity in serum and on lymphocytes of MRL/Mp-lpr/lpr mice correlates with disease onsetClinical and Experimental Immunology, 1994
- Direct Association of Adenosine Deaminase with a T Cell Activation Antigen, CD26Science, 1993
- A marker for neoplastic progression of human melanocytes is a cell surface ectopeptidase.The Journal of Experimental Medicine, 1993
- A New Sulfonated Tetrazolium Salt That Produces a Highly Water-Soluble Formazan Dye.CHEMICAL & PHARMACEUTICAL BULLETIN, 1993
- Expression of the rat CD26 Antigen (dipeptidyl peptidase IV) on subpopulations of rat lymphocytesCellular Immunology, 1991
- Human CD4 helper T cell activation: functional involvement of two distinct collagen receptors, 1F7 and VLA integrin family.The Journal of Experimental Medicine, 1990
- Deficiency of membrane-bound dipeptidyl aminopeptidase IV in a certain rat strainCellular and Molecular Life Sciences, 1987
- In Vivo Activated T Lymphocytes in the Peripheral Blood and Cerebrospinal Fluid of Patients with Multiple SclerosisThe New England Journal of Medicine, 1985